<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38611624</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Long COVID: Long-Term Impact of SARS-CoV2.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">711</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics14070711</ELocationID><Abstract><AbstractText>Four years post-pandemic, SARS-CoV-2 continues to affect many lives across the globe. An estimated 65 million people suffer from long COVID, a term used to encapsulate the post-acute sequelae of SARS-CoV-2 infections that affect multiple organ systems. Known symptoms include chronic fatigue syndrome, brain fog, cardiovascular issues, autoimmunity, dysautonomia, and clotting due to inflammation. Herein, we review long COVID symptoms, the proposed theories behind the pathology, diagnostics, treatments, and the clinical trials underway to explore treatments for viral persistence, autonomic and cognitive dysfunctions, sleep disturbances, fatigue, and exercise intolerance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Makhluf</LastName><ForeName>Huda</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Natural Sciences, National University, San Diego, CA 92123, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infectious Disease, La Jolla Institute, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madany</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Infectious Disease, La Jolla Institute, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health Sciences, University of California, Irvine, CA 92697, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Infectious Disease, La Jolla Institute, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">long COVID (LC)</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2 (PASC)</Keyword><Keyword MajorTopicYN="N">precision</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38611624</ArticleId><ArticleId IdType="pmc">PMC11011397</ArticleId><ArticleId IdType="doi">10.3390/diagnostics14070711</ArticleId><ArticleId IdType="pii">diagnostics14070711</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.-H., Zhang Y., Dorgham K., Philippot Q., Rosain J., B&#xe9;ziat V., et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., Dhodapkar R.M., Lu P., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., et al. Distinguishing features of Long COVID identified through immune profiling. Nature. 2023;623:139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>El Hajjar A.H., El Helou M.C., Bayat A., Cantillon D., Singh T., Taigen T., Moudgil R. Ventricular Tachycardia as a Late Complication of COVID-19 in a Young Patient with no History of Cardiovascular Disease. CJC Open. 2024:S2589790X24000465. doi: 10.1016/j.cjco.2024.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjco.2024.01.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa R.H., Moustafa A. Beyond acute infection: Molecular mechanisms underpinning cardiovascular complications in long COVID. Front. Cardiovasc. Med. 2024;11:1268571. doi: 10.3389/fcvm.2024.1268571.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2024.1268571</ArticleId><ArticleId IdType="pmc">PMC10942004</ArticleId><ArticleId IdType="pubmed">38495940</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobler D.L., Pruzansky A.J., Naderi S., Ambrosy A.P., Slade J.J. Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician. Curr. Atheroscler. Rep. 2022;24:563&#x2013;570. doi: 10.1007/s11883-022-01032-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-022-01032-8</ArticleId><ArticleId IdType="pmc">PMC9065238</ArticleId><ArticleId IdType="pubmed">35507278</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellgren L., Birberg Thornberg U., Samuelsson K., Levi R., Divanoglou A., Blystad I. Brain MRI and neuropsychological findings at long-term follow-up after COVID-19 hospitalisation: An observational cohort study. BMJ Open. 2021;11:e055164. doi: 10.1136/bmjopen-2021-055164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-055164</ArticleId><ArticleId IdType="pmc">PMC8551746</ArticleId><ArticleId IdType="pubmed">34706965</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Zhou Z., Yang D., Zhao W., Zeng M., Xie X., Du Y., Jiang Y., Zhou X., Yang W., et al. Persistent white matter changes in recovered COVID-19 patients at the 1-year follow-up. Brain. 2022;145:1830&#x2013;1838. doi: 10.1093/brain/awab435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab435</ArticleId><ArticleId IdType="pmc">PMC8754808</ArticleId><ArticleId IdType="pubmed">34918020</ArticleId></ArticleIdList></Reference><Reference><Citation>Iosifescu A.L., Hoogenboom W.S., Buczek A.J., Fleysher R., Duong T.Q. New-onset and persistent neurological and psychiatric sequelae of COVID-19 compared to influenza: A retrospective cohort study in a large New York City healthcare network. Int. J. Methods Psychiatr. Res. 2022;31:e1914. doi: 10.1002/mpr.1914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mpr.1914</ArticleId><ArticleId IdType="pmc">PMC9349863</ArticleId><ArticleId IdType="pubmed">35706352</ArticleId></ArticleIdList></Reference><Reference><Citation>Titze-de-Almeida R., Ara&#xfa;jo Lacerda P.H., Oliveira E.P.D., Oliveira M.E.F.D., Vianna Y.S.S., Costa A.M., Pereira Dos Santos E., Gu&#xe9;rard L.M.C., Ferreira M.A.D.M., Rodrigues Dos Santos I.C., et al. Sleep and memory complaints in long COVID: An insight into clustered psychological phenotypes. PeerJ. 2024;12:e16669. doi: 10.7717/peerj.16669.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.16669</ArticleId><ArticleId IdType="pmc">PMC10836207</ArticleId><ArticleId IdType="pubmed">38313024</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouwmans P., Malahe S.R.K., Messchendorp A.L., Vart P., Imhof C., Sanders J.-S., Gansevoort R.T., De Vries A.P.J., Abrahams A.C., Bemelman F.J., et al. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study. Int. J. Infect. Dis. 2024;142:106990. doi: 10.1016/j.ijid.2024.106990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2024.106990</ArticleId><ArticleId IdType="pubmed">38428480</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J.Y., Boparai M.S., Shi C., Henninger E.M., Rangareddy M., Veeraraghavan S., Mirhaji P., Fisher M.C., Duong T.Q. Long-term outcomes of COVID-19 survivors with hospital AKI: Association with time to recovery from AKI. Nephrol. Dial. Transplant. 2023;38:2160&#x2013;2169. doi: 10.1093/ndt/gfad020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfad020</ArticleId><ArticleId IdType="pubmed">36702551</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhao Y., Wang J., Zheng X., Xu D., Lv J., Yang L. Long-term renal outcomes of patients with COVID-19: A meta-analysis of observational studies. J. Nephrol. 2023;36:2441&#x2013;2456. doi: 10.1007/s40620-023-01731-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-023-01731-8</ArticleId><ArticleId IdType="pubmed">37787893</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R., Conte C., Lanzani C., Benedetti F., Roveri L., Mazza M.G., Brioni E., Giacalone G., Canti V., Sofia V., et al. Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study. PLoS ONE. 2020;15:e0239570. doi: 10.1371/journal.pone.0239570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239570</ArticleId><ArticleId IdType="pmc">PMC7556454</ArticleId><ArticleId IdType="pubmed">33052920</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameil M.A., Marzouk R.E., Elsebaie A.H., Rozaik S.E. Long-term clinical and biochemical residue after COVID-19 recovery. Egypt Liver J. 2021;11:74. doi: 10.1186/s43066-021-00144-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43066-021-00144-1</ArticleId><ArticleId IdType="pmc">PMC8435147</ArticleId><ArticleId IdType="pubmed">34777873</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang V., Fisher M., Hou W., Zhang L., Duong T.Q. Incidence of New-Onset Hypertension Post&#x2013;COVID-19: Comparison With Influenza. Hypertension. 2023;80:2135&#x2013;2148. doi: 10.1161/HYPERTENSIONAHA.123.21174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.123.21174</ArticleId><ArticleId IdType="pubmed">37602375</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell&#x2019;Aquila K., Lee J., Wang S.H., Alamuri T.T., Jennings R., Tang H., Mahesh S., Leong T.J., Fleysher R., Henninger E.M., et al. Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID -19 patients: Comparison with influenza and pre-pandemic data. Diabetes Obes. Metab. 2023;25:2482&#x2013;2494. doi: 10.1111/dom.15120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.15120</ArticleId><ArticleId IdType="pubmed">37254311</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino F., Amiel S.A., Zimmet P., Alberti G., Bornstein S., Eckel R.H., Mingrone G., Boehm B., Cooper M.E., Chai Z., et al. New-Onset Diabetes in COVID-19. N. Engl. J. Med. 2020;383:789&#x2013;790. doi: 10.1056/NEJMc2018688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2018688</ArticleId><ArticleId IdType="pmc">PMC7304415</ArticleId><ArticleId IdType="pubmed">32530585</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T., Anton M.C., Sivakumar T. New-onset diabetes in &#x201c;long COVID&#x201d;. J. Diabetes. 2021;13:693&#x2013;694. doi: 10.1111/1753-0407.13187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-0407.13187</ArticleId><ArticleId IdType="pmc">PMC8251301</ArticleId><ArticleId IdType="pubmed">33893710</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha D.B., Budhathoki P., Raut S., Adhikari S., Ghimire P., Thapaliya S., Rabaan A.A., Karki B.J. New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis. World J. Virol. 2021;10:275&#x2013;287. doi: 10.5501/wjv.v10.i5.275.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v10.i5.275</ArticleId><ArticleId IdType="pmc">PMC8474977</ArticleId><ArticleId IdType="pubmed">34631477</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. Risks and burdens of incident diabetes in long COVID: A cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu A.Y., Wang S.H., Duong T.Q. Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: A retrospective cohort study. BMJ Open Diab. Res. Care. 2023;11:e003257. doi: 10.1136/bmjdrc-2022-003257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2022-003257</ArticleId><ArticleId IdType="pmc">PMC10276968</ArticleId><ArticleId IdType="pubmed">37295808</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. What causes Long COVID? Here are the three leading theories. Science. 2022;376:1261&#x2013;1265. doi: 10.1126/science.add4297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.add4297</ArticleId><ArticleId IdType="pubmed">35709281</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. ME/CFS and Long COVID share similar symptoms and biological abnormalities: Road map to the literature. Front. Med. 2023;10:1187163. doi: 10.3389/fmed.2023.1187163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term gastrointestinal outcomes of COVID-19. Nat. Commun. 2023;14:983. doi: 10.1038/s41467-023-36223-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-36223-7</ArticleId><ArticleId IdType="pmc">PMC9992516</ArticleId><ArticleId IdType="pubmed">36882400</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C.-Y., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S.-C., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.-H., Wood J., Yal&#xe7;&#x131;n B., Taylor K.R., Dutton S., Acosta-Alvarez L., et al. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. Neuroscience. 2022:preprint. doi: 10.1101/2022.01.07.475453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S., Abdallah S.J., Corrales-Medina V., Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: A narrative review. Ther. Adv. Infect. 2021;8:204993612110093. doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H., Quach T.C., Tiwari A., Bonilla A.E., Miglis M., Yang P.C., Eggert L.E., Sharifi H., Horomanski A., Subramanian A., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic. Front. Neurol. 2023;14:1090747. doi: 10.3389/fneur.2023.1090747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp G.C., Fraser A., Sawyer G., Kountourides G., Easey K.E., Ford G., Olszewska Z., Howe L.D., Lawlor D.A., Alvergne A., et al. The COVID-19 pandemic and the menstrual cycle: Research gaps and opportunities. Int. J. Epidemiol. 2022;51:691&#x2013;700. doi: 10.1093/ije/dyab239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab239</ArticleId><ArticleId IdType="pmc">PMC8690231</ArticleId><ArticleId IdType="pubmed">34865021</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.-S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F., Catalan P., Rodriguez-Grande C., Adan J., Rodriguez-Gonzalez C., Mu&#xf1;oz P., Aldamiz T., Diez C., Perez L., Fanciulli C., et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis. 2022;22:211. doi: 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceulemans L.J., Khan M., Yoo S.-J., Zapiec B., Van Gerven L., Van Slambrouck J., Vanstapel A., Van Raemdonck D., Vos R., Wauters E., et al. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19. Lancet Respir. Med. 2021;9:e78&#x2013;e79. doi: 10.1016/S2213-2600(21)00240-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00240-X</ArticleId><ArticleId IdType="pmc">PMC8189667</ArticleId><ArticleId IdType="pubmed">34118186</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C.C.L., Goh D., Lim X., Tien T.Z., Lim J.C.T., Lee J.N., Tan B., Tay Z.E.A., Wan W.Y., Chen E.X., et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71:226&#x2013;229. doi: 10.1136/gutjnl-2021-324280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S., Palm P., Nygaard U., Bundgaard H., Petersen M.N.S., Rosenkilde S., Thorsted A.B., Ersb&#xf8;ll A.K., Thygesen L.C., Nielsen S.D., et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0&#x2013;14 years and matched controls in Denmark (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolesc. Health. 2022;6:614&#x2013;623. doi: 10.1016/S2352-4642(22)00154-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00154-7</ArticleId><ArticleId IdType="pmc">PMC9221683</ArticleId><ArticleId IdType="pubmed">35752194</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller F., Nguyen V., Navaratnam A.M., Shrotri M., Kovar J., Hayward A.C., Fragaszy E., Aldridge R.W., Hardelid P. Prevalence of persistent symptoms in children during the COVID-19 pandemic: Evidence from a household cohort study in England and Wales. Pediatrics. 2021:preprint. doi: 10.1097/INF.0000000000003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003715</ArticleId><ArticleId IdType="pmc">PMC9645448</ArticleId><ArticleId IdType="pubmed">36375098</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Lee G.M., Razzaghi H., Lorman V., Mejias A., Pajor N.M., Thacker D., Webb R., Dickinson K., Bailey L.C., et al. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents. JAMA Pediatr. 2022;176:1000. doi: 10.1001/jamapediatrics.2022.2800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2800</ArticleId><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M., Tesch F., Batram M., Jacob J., Loser F., Weidinger O., Wende D., Vivirito A., Toepfner N., Seifert M., et al. Post COVID-19 in children, adolescents, and adults: Results of a matched cohort study including more than 150,000 individuals with COVID-19. Epidemiology. 2021:preprint. doi: 10.1101/2021.10.21.21265133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.21.21265133</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S., Dam Nielsen S., Nygaard U., Bundgaard H., Palm P., Rotvig C., Vinggaard Christensen A. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolesc. Health. 2022;6:240&#x2013;248. doi: 10.1016/S2352-4642(22)00004-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E., Sudre C.H., Canas L.S., Bhopal S.S., Hughes R.C., Antonelli M., Murray B., Kl&#xe4;ser K., Kerfoot E., Chen L., et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc. Health. 2021;5:708&#x2013;718. doi: 10.1016/S2352-4642(21)00198-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., Gamirova A., Shikhaleva A., Andreeva M., Blyuss O., El-Taravi Y., DunnGalvin A., Comberiati P., et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur. Respir. J. 2022;59:2101341. doi: 10.1183/13993003.01341-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Dun-Dery F., Xie J., Winston K., Burstein B., Gravel J., Emsley J., Sabhaney V., Zemek R., Berthelot S., Beer D., et al. Post&#x2013;COVID-19 Condition in Children 6 and 12 Months After Infection. JAMA Netw. Open. 2023;6:e2349613. doi: 10.1001/jamanetworkopen.2023.49613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.49613</ArticleId><ArticleId IdType="pmc">PMC10755606</ArticleId><ArticleId IdType="pubmed">38153737</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad A., Janda A., Renk H., Stich M., Frieh P., Kaier K., Lohrmann F., Nieters A., Willems A., Huzly D., et al. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study. eBioMedicine. 2022;84:104245. doi: 10.1016/j.ebiom.2022.104245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104245</ArticleId><ArticleId IdType="pmc">PMC9495281</ArticleId><ArticleId IdType="pubmed">36155957</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y.-B., Zeng N., Yuan K., Tian S.-S., Yang Y.-B., Gao N., Chen X., Zhang A.-Y., Kondratiuk A.L., Shi P.-P., et al. Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. J. Infect. Public Health. 2023;16:660&#x2013;672. doi: 10.1016/j.jiph.2023.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.03.005</ArticleId><ArticleId IdType="pmc">PMC9990879</ArticleId><ArticleId IdType="pubmed">36931142</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hare A.M., Vig E.K., Iwashyna T.J., Fox A., Taylor J.S., Viglianti E.M., Butler C.R., Vranas K.C., Helfand M., Tuepker A., et al. Complexity and Challenges of the Clinical Diagnosis and Management of Long COVID. JAMA Netw. Open. 2022;5:e2240332. doi: 10.1001/jamanetworkopen.2022.40332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.40332</ArticleId><ArticleId IdType="pmc">PMC9634500</ArticleId><ArticleId IdType="pubmed">36326761</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese J.T., Blau H., Casiraghi E., Bergquist T., Loomba J.J., Callahan T.J., Laraway B., Antonescu C., Coleman B., Gargano M., et al. Generalisable long COVID subtypes: Findings from the NIH N3C and RECOVER programmes. eBioMedicine. 2023;87:104413. doi: 10.1016/j.ebiom.2022.104413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104413</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff E.R., Madlock-Brown C., Baratta J.M., Bhatia A., Davis H., Girvin A., Hill E., Kelly E., Kostka K., Loomba J., et al. Coding long COVID: Characterizing a new disease through an ICD-10 lens. BMC Med. 2023;21:58. doi: 10.1186/s12916-023-02737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02737-6</ArticleId><ArticleId IdType="pmc">PMC9931566</ArticleId><ArticleId IdType="pubmed">36793086</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff E.R., Girvin A.T., Bennett T.D., Bhatia A., Brooks I.M., Deer R.R., Dekermanjian J.P., Jolley S.E., Kahn M.G., Kostka K., et al. Identifying who has long COVID in the USA: A machine learning approach using N3C data. Lancet Digit. Health. 2022;4:e532&#x2013;e541. doi: 10.1016/S2589-7500(22)00048-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00048-6</ArticleId><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridger Staatz C., Bann D., Ploubidis G.B., Goodman A., Silverwood R.J. Age of First Overweight and Obesity, COVID-19 and Long COVID in Two British Birth Cohorts. J. Epidemiol. Glob. Health. 2023;13:140&#x2013;153. doi: 10.1007/s44197-023-00093-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s44197-023-00093-5</ArticleId><ArticleId IdType="pmc">PMC9945825</ArticleId><ArticleId IdType="pubmed">36811824</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Liu X., Le W., Xie L., Li H., Wen W., Wang S., Ma S., Huang Z., Ye J., et al. A human circulating immune cell landscape in aging and COVID-19. Protein Cell. 2020;11:740&#x2013;770. doi: 10.1007/s13238-020-00762-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-020-00762-2</ArticleId><ArticleId IdType="pmc">PMC7417788</ArticleId><ArticleId IdType="pubmed">32780218</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B.A., Lim E.Y., Metaxaki M., Jackson S., Mactavous L., NIHR BioResource. Lyons P.A., Doffinger R., Bradley J.R., Smith K.G.C., et al. Spontaneous, persistent, T cell&#x2013;dependent IFN-&#x3b3; release in patients who progress to Long COVID. Sci. Adv. 2024;10:eadi9379. doi: 10.1126/sciadv.adi9379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adi9379</ArticleId><ArticleId IdType="pmc">PMC10881041</ArticleId><ArticleId IdType="pubmed">38381822</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeem S., Oros S.M., Adams C.S., Rakesh G. Treatment of Cognitive Deficits and Behavioral Symptoms Following COVID-19-Associated Autoimmune Encephalitis with Intravenous Immunoglobulin: A Case Report and Review of the Literature. Cureus. 2023;15:e51071. doi: 10.7759/cureus.51071.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.51071</ArticleId><ArticleId IdType="pmc">PMC10749582</ArticleId><ArticleId IdType="pubmed">38146337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.C., Devason A.S., Umana I.C., Cox T.O., Dohnalov&#xe1; L., Litichevskiy L., Perla J., Lundgren P., Etwebi Z., Izzo L.T., et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;4867.e20. doi: 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheppke K.A., Pepe P.E., Jui J., Crowe R.P., Scheppke E.K., Klimas N.G., Marty A.M. Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: A report of signal index cases and call for targeted research. Am. J. Emerg. Med. 2024;75:122&#x2013;127. doi: 10.1016/j.ajem.2023.09.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2023.09.051</ArticleId><ArticleId IdType="pubmed">37944296</ArticleId></ArticleIdList></Reference><Reference><Citation>Control of COVID-19 Outbreaks in Long Term Care.  [(accessed on 1 January 2024)];2020  Available online:  https://classic.clinicaltrials.gov/ct2/show/NCT04448119.</Citation></Reference><Reference><Citation>RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms (RECOVER-VITAL)  [(accessed on 1 January 2024)];2022  Available online:  https://classic.clinicaltrials.gov/ct2/show/NCT05595369.</Citation></Reference><Reference><Citation>SOLIDARITY Finland Long-COVID (Remdesivir Long-Term Follow-up Study of COVID Patients)  [(accessed on 1 January 2024)];2021  Available online:  https://clinicaltrials.gov/study/NCT04978259.</Citation></Reference><Reference><Citation>SOLIDARITY Finland Plus Long-COVID.  [(accessed on 1 January 2024)];2022  Available online:  https://clinicaltrials.gov/study/NCT05220280.</Citation></Reference><Reference><Citation>RECLAIM: Recovering from COVID-19 Lingering Symptoms Adaptive Integrative Medicine (RECLAIM)  [(accessed on 1 January 2024)];2022  Available online:  https://classic.clinicaltrials.gov/ct2/show/NCT05513560?term=NCT05513560&amp;draw=1&amp;rank=1.</Citation></Reference><Reference><Citation>Zhao S., Shibata K., Hellyer P.J., Trender W., Manohar S., Hampshire A., Husain M. Rapid vigilance and episodic memory decrements in COVID-19 survivors. Brain Commun. 2022;4:fcab295. doi: 10.1093/braincomms/fcab295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab295</ArticleId><ArticleId IdType="pmc">PMC8807287</ArticleId><ArticleId IdType="pubmed">35128398</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Martin E.M., Reuken P.A., Scholcz A., Ganse-Dumrath A., Srowig A., Utech I., Kozik V., Radscheidt M., Brodoehl S., et al. Long COVID is associated with severe cognitive slowing: A multicentre cross-sectional study. eClinicalMedicine. 2024;68:102434. doi: 10.1016/j.eclinm.2024.102434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2024.102434</ArticleId><ArticleId IdType="pmc">PMC10839583</ArticleId><ArticleId IdType="pubmed">38318123</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau R.I., Su Q., Lau I.S.F., Ching J.Y.L., Wong M.C.S., Lau L.H.S., Tun H.M., Mok C.K.P., Chau S.W.H., Tse Y.K., et al. A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): A randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis. 2023;24:256&#x2013;265. doi: 10.1016/S1473-3099(23)00685-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00685-0</ArticleId><ArticleId IdType="pubmed">38071990</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy of Lactobacillus Paracasei PS23 for Patients with Post-COVID-19 Syndrome.  [(accessed on 1 January 2024)];2023  Available online:  https://classic.clinicaltrials.gov/ct2/show/NCT05813899.</Citation></Reference><Reference><Citation>Malik M., Suboc T.M., Tyagi S., Salzman N., Wang J., Ying R., Tanner M.J., Kakarla M., Baker J.E., Widlansky M.E. Lactobacillus plantarum 299v Supplementation Improves Vascular Endothelial Function and Reduces Inflammatory Biomarkers in Men With Stable Coronary Artery Disease. Circ. Res. 2018;123:1091&#x2013;1102. doi: 10.1161/CIRCRESAHA.118.313565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.313565</ArticleId><ArticleId IdType="pmc">PMC6205737</ArticleId><ArticleId IdType="pubmed">30355158</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of Lp299v on Vascular Function in Patients with PASC.  [(accessed on 1 January 2024)];2023  Available online:  https://clinicaltrials.gov/study/NCT05227170.</Citation></Reference><Reference><Citation>Post COVID-19 Syndrome and the Gut-Lung Axis.  [(accessed on 1 January 2024)];2023  Available online:  https://clinicaltrials.gov/study/NCT04813718.</Citation></Reference><Reference><Citation>Dos Santos Alves R.P., Timis J., Miller R., Valentine K., Pinto P.B.A., Gonzalez A., Regla-Nava J.A., Maule E., Nguyen M.N., Shafee N., et al. Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice. Nat. Commun. 2024;15:787. doi: 10.1038/s41467-024-45043-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-45043-2</ArticleId><ArticleId IdType="pmc">PMC10817949</ArticleId><ArticleId IdType="pubmed">38278784</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms (RECOVER-VITAL)  [(accessed on 1 January 2024)];2023  Available online:  https://classic.clinicaltrials.gov/ct2/show/NCT05965726.</Citation></Reference><Reference><Citation>RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms.  [(accessed on 1 January 2024)];2024  Available online:  https://clinicaltrials.gov/study/NCT05965752.</Citation></Reference><Reference><Citation>Bramante C.T., Buse J.B., Liebovitz D.M., Nicklas J.M., Puskarich M.A., Cohen K., Belani H.K., Anderson B.J., Huling J.D., Tignanelli C.J., et al. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): A multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect. Dis. 2023;23:1119&#x2013;1129. doi: 10.1016/S1473-3099(23)00299-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00299-2</ArticleId><ArticleId IdType="pmc">PMC11259948</ArticleId><ArticleId IdType="pubmed">37302406</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S., Sun S., Geng L., Song M., Wang W., Ye Y., Ji Q., Zou Z., Wang S., He X., et al. Caloric Restriction Reprograms the Single-Cell Transcriptional Landscape of Rattus Norvegicus Aging. Cell. 2020;180:984&#x2013;1001.e22. doi: 10.1016/j.cell.2020.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.008</ArticleId><ArticleId IdType="pubmed">32109414</ArticleId></ArticleIdList></Reference><Reference><Citation>Heilbronn L.K., De Jonge L., Frisard M.I., DeLany J.P., Larson-Meyer D.E., Rood J., Nguyen T., Martin C.K., Volaufova J., Most M.M., et al. Effect of 6-Month Calorie Restriction on Biomarkers of Longevity, Metabolic Adaptation, and Oxidative Stress in Overweight Individuals: A Randomized Controlled Trial. JAMA. 2006;295:1539. doi: 10.1001/jama.295.13.1539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.13.1539</ArticleId><ArticleId IdType="pmc">PMC2692623</ArticleId><ArticleId IdType="pubmed">16595757</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundler F., Mesnage R., Cerrada A., Wilhelmi De Toledo F. Improvements during long-term fasting in patients with long COVID&#x2014;A case series and literature review. Front. Nutr. 2023;10:1195270. doi: 10.3389/fnut.2023.1195270.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2023.1195270</ArticleId><ArticleId IdType="pmc">PMC10651743</ArticleId><ArticleId IdType="pubmed">38024352</ArticleId></ArticleIdList></Reference><Reference><Citation>Luda K.M., Longo J., Kitchen-Goosen S.M., Duimstra L.R., Ma E.H., Watson M.J., Oswald B.M., Fu Z., Madaj Z., Kupai A., et al. Ketolysis drives CD8+ T cell effector function through effects on histone acetylation. Immunity. 2023;56:2021&#x2013;2035.e8. doi: 10.1016/j.immuni.2023.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2023.07.002</ArticleId><ArticleId IdType="pmc">PMC10528215</ArticleId><ArticleId IdType="pubmed">37516105</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouter K.E., Van Raalte D.H., Groen A.K., Nieuwdorp M. Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction. Gastroenterology. 2017;152:1671&#x2013;1678. doi: 10.1053/j.gastro.2016.12.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.12.048</ArticleId><ArticleId IdType="pubmed">28192102</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D.D., Qi Q., Wang Z., Usyk M., Sotres-Alvarez D., Mattei J., Tamez M., Gellman M.D., Daviglus M., Hu F.B., et al. The Gut Microbiome Modifies the Association Between a Mediterranean Diet and Diabetes in USA Hispanic/Latino Population. J. Clin. Endocrinol. Metab. 2022;107:e924&#x2013;e934. doi: 10.1210/clinem/dgab815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab815</ArticleId><ArticleId IdType="pmc">PMC8851916</ArticleId><ArticleId IdType="pubmed">34747479</ArticleId></ArticleIdList></Reference><Reference><Citation>Falsetti L., Zaccone V., Santoro L., Santini S., Guerrieri E., Giuliani L., Viticchi G., Cataldi S., Gasbarrini A., Landi F., et al. The Relationship between Post-COVID Syndrome and the Burden of Comorbidities Assessed Using the Charlson Comorbidity Index. Medicina. 2023;59:1583. doi: 10.3390/medicina59091583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina59091583</ArticleId><ArticleId IdType="pmc">PMC10533175</ArticleId><ArticleId IdType="pubmed">37763702</ArticleId></ArticleIdList></Reference><Reference><Citation>Link V.M., Subramanian P., Cheung F., Han K.L., Stacy A., Chi L., Sellers B.A., Koroleva G., Courville A.B., Mistry S., et al. Differential peripheral immune signatures elicited by vegan versus ketogenic diets in humans. Nat. Med. 2024;30:560&#x2013;572. doi: 10.1038/s41591-023-02761-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02761-2</ArticleId><ArticleId IdType="pmc">PMC10878979</ArticleId><ArticleId IdType="pubmed">38291301</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrea L., Grant W.B., Frias-Toral E., Vetrani C., Verde L., De Alteriis G., Docimo A., Savastano S., Colao A., Muscogiuri G. Dietary Recommendations for Post-COVID-19 Syndrome. Nutrients. 2022;14:1305. doi: 10.3390/nu14061305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14061305</ArticleId><ArticleId IdType="pmc">PMC8954128</ArticleId><ArticleId IdType="pubmed">35334962</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf8;rklund G., Dadar M., Pen J.J., Chirumbolo S., Aaseth J. Chronic fatigue syndrome (CFS): Suggestions for a nutritional treatment in the therapeutic approach. Biomed. Pharmacother. 2019;109:1000&#x2013;1007. doi: 10.1016/j.biopha.2018.10.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.10.076</ArticleId><ArticleId IdType="pubmed">30551349</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Topol E. Solving the puzzle of Long COVID. Science. 2024;383:830&#x2013;832. doi: 10.1126/science.adl0867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adl0867</ArticleId><ArticleId IdType="pubmed">38386747</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>